IFNG and glioblastoma: Additionally, viability studies performed on these human GBM cell lines using CellTitre-Glo showed that treatment with GSK126 and/or the combination of GSK126 and IFNγ had no detrimental effect on cell growth in vitro (Supplementary Figure 1C).